Abpro Holdings, Inc. (ABPO) stock
ABPOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ABPWW
$0.41+0.00 (+0.11%)
Close on Oct 19, 2026Market cap $2.41MP/E –Yield –
Abpro operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Abpro's operating cash flow for the twelve months ending Jun 30, 2026 was -$6.59M. For fiscal 2025 it was -$6.01M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.01M | – |
| FY2024 | Dec 31, 2024 | -$9.03M | – |
| FY2023 | Dec 31, 2023 | -$7.40M | – |
| FY2022 | Dec 31, 2022 | -$1.18M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.05M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.08M | – |
| Q4 FY2025 | Dec 31, 2025 | -$620.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.83M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.05M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.50M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.37M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.85M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.90M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.28M | – |
| Q2 FY2023 | Jun 30, 2023 | -$129.78K | – |
| Q1 FY2023 | Mar 31, 2023 | -$97.22K | – |
| Q4 FY2022 | Dec 31, 2022 | -$128.10K | – |
| Q3 FY2022 | Sep 30, 2022 | -$94.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$35.54K | – |
| Q1 FY2022 | Mar 31, 2022 | -$927.32K | – |
See a number that looks wrong?